trans-2-Methylcyclopropanamine hydrochloride

Catalog No. :
ACVUEW359
CAS No. :
97291-62-8
Molecular Formula :
C4H10ClN
Molecular Weight :
107.58

IUPAC Name:(1R,2R)-2-methylcyclopropan-1-amine hydrochloride

trans-2-Methylcyclopropanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$621.00Login to see priceIn stockInquiry
250mg95%$992.00Login to see priceIn stockInquiry
500mg95%$1653.00Login to see priceIn stockInquiry
1g95%$2478.00Login to see priceIn stockInquiry
5g95%$7434.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-2-Methylcyclopropanamine hydrochloride
IUPAC Name(1R,2R)-2-methylcyclopropan-1-amine hydrochloride
MDL No.MFCD27997454
Molecular FormulaC4H10ClN
Molecular Weight107.58
SMILESC[C@@H]1C[C@H]1N.Cl
InChI KeyDGEKNIYQAIAEGO-VKKIDBQXSA-N
SynonymTRANS-2-METHYLCYCLOPROPANAMINE HYDROCHLORIDE;Trans-2-Methylcyclopropanamine Hydrochloride(WX601308);(1R,2R)-2-methylcyclopropan-1-amine;trans-2-Methyl-cyclopropylamine hydrochloride;rac-(1R,2R)-2-methylcyclopropane-1-amine HCl,trans;(1R,2R)-rel-2-methyl-Cyclopropanamine hydrochloride;rac-(1R,2R)-2-Methylcyclopropanamine HCl,trans
CAS No.97291-62-8
PubChem CID118798395

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVUEW359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUEW359 route product structure diagram
    ACVUEW35997291-62-8 In Stock
Inquiry

2. ACVUEW359 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUEW359 route product structure diagram
    ACVUEW35997291-62-8 In Stock
Inquiry

Comments (0)